HeartSciences Inc. (HSCS) · Nov 6, 2026 · Other events
Proxy supplement — Seven shareholder demand letters; November 19 meeting timing unchanged
HeartSciences filed a proxy supplement after seven shareholder demands over its Fortitude merger disclosures. The November 19 vote remains on schedule.
HeartSciences is in the middle of a full business pivot: its AI-enabled ECG company is seeking shareholder approval to combine with Fortitude, a Zcash-focused digital-asset mining platform, with existing HeartSciences holders expected to retain only about 5% of the combined equity. The filing adds legal friction, but not a new transaction problem. HeartSciences says it received seven shareholder demand letters alleging that the preliminary and definitive proxy statements omitted material information. 〔0〕 The company denies the allegations and says the added disclosures are voluntary, intended to avoid nuisance litigation, delay, and defense expense. 〔1〕 The immediate execution risk is contained. The special meeting remains scheduled for November 19, so this supplement does not currently push back the shareholder vote or signal that the merger agreement itself has changed. 〔2〕 The new information also clarifies that Fortitude had no debt and approximately $12.2 million of cash as of May 31, 2026, while its mined digital assets are routinely sold or monetized to fund operations and capital investment. Bottom line: This is a modestly negative procedural development rather than a change to the merger thesis. The vote is still on schedule, but seven demands add evidence of shareholder challenge and a small layer of closing and litigation friction to an already consequential pivot.
Special shareholder meeting and merger vote, November 19, 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!